Jane Street’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Jane Street’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,250	Closed	-$193K	–	11674
2025 Q4	$193K	Buy	+10,250	New	+$80.3K	﹤0.01%	9753
2021 Q2	–	Sell	-53	Closed	-$26K	–	9802
2021 Q1	$26K	Buy	+53	New	+$23K	﹤0.01%	8946
2018 Q3	–	Sell	-3	Closed	-$12K	–	5110
2018 Q2	$12K	Buy	+3	New	+$12K	﹤0.01%	4878
2016 Q2	–	Sell	-4	Closed	-$30K	–	4075
2016 Q1	$30K	Sell	4 -8	-67%	-$55.4K	﹤0.01%	3976
2015 Q4	$108K	Sell	12 -36	-75%	-$362K	﹤0.01%	3778
2015 Q3	$592K	Buy	+48	New	+$322K	﹤0.01%	2130

Other funds holding CANF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's CANF Position: Q1 2026 in Review

Jane Street sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026, closing a stake of 10,250 shares — an estimated $193K sold.

Jane Street first reported a position in CANF in Q3 2015 and held it in 6 quarters. The position peaked at $592K in Q3 2015. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

Jane Street reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Jane Street sold 10,250 Can-Fite BioPharma American Depositary Shares shares in Q1 2026, an estimated $193K.
Jane Street first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and held it in 6 quarters.
Jane Street's Can-Fite BioPharma American Depositary Shares position peaked at $592K in Q3 2015.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.